Copyright
©2010 Baishideng. All rights reserved.
World J Hepatol. Mar 27, 2010; 2(3): 103-113
Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.103
Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.103
Medical treatment of unresectable hepatocellular carcinoma: Going beyond sorafenib
Camillo Porta, Medical Oncology and Laboratory of Preclinical Oncology and Experimental Therapies, IRCCS San Matteo University Hospital Foundation, Pavia I-27100, Italy
Chiara Paglino, Medical Oncology, IRCCS San Matteo University Hospital Foundation, Pavia I-27100, Italy
Author contributions: Porta C and Paglino C equally contributed to this review.
Correspondence to: Camillo Porta, MD, Medical Oncology and Laboratory of Preclinical Oncology and Experimental Therapies, IRCCS San Matteo University Hospital Foundation, Piazzale C Golgi 19, Pavia I-27100, Italy. c.porta@smatteo.pv.it
Telephone: +39-382-501355 Fax: +39-382-502442
Received: August 17, 2009
Revised: January 14, 2010
Accepted: January 21, 2010
Published online: March 27, 2010
Revised: January 14, 2010
Accepted: January 21, 2010
Published online: March 27, 2010
Core Tip